Q3 2024 EPS Estimates for Henry Schein, Inc. (NASDAQ:HSIC) Lowered by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Leerink Partnrs cut their Q3 2024 earnings per share (EPS) estimates for Henry Schein in a research note issued to investors on Tuesday, July 9th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $1.37 per share for the quarter, down from their previous estimate of $1.38. The consensus estimate for Henry Schein’s current full-year earnings is $5.16 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.40 EPS, FY2025 earnings at $5.52 EPS, FY2026 earnings at $6.03 EPS and FY2027 earnings at $6.60 EPS.

Several other equities research analysts also recently issued reports on the company. Piper Sandler reiterated an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a report on Friday, June 21st. UBS Group decreased their price objective on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. Barrington Research restated an “outperform” rating and set a $92.00 price target on shares of Henry Schein in a research note on Friday, July 5th. Finally, Evercore ISI dropped their price objective on Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research note on Tuesday. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $80.73.

Henry Schein Trading Up 0.1 %

HSIC opened at $65.15 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The company’s 50-day moving average is $68.66 and its 200 day moving average is $72.24. The firm has a market capitalization of $8.34 billion, a PE ratio of 22.01, a P/E/G ratio of 1.58 and a beta of 0.87. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.21 earnings per share.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Graham Capital Management L.P. bought a new stake in shares of Henry Schein during the 3rd quarter worth $439,000. Deutsche Bank AG boosted its holdings in shares of Henry Schein by 10.2% in the 3rd quarter. Deutsche Bank AG now owns 379,208 shares of the company’s stock worth $28,156,000 after purchasing an additional 35,209 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Henry Schein during the 3rd quarter valued at about $46,000. Wellington Management Group LLP raised its holdings in shares of Henry Schein by 4.3% during the 3rd quarter. Wellington Management Group LLP now owns 38,695 shares of the company’s stock valued at $2,873,000 after buying an additional 1,599 shares in the last quarter. Finally, DNB Asset Management AS lifted its position in Henry Schein by 16.1% in the 4th quarter. DNB Asset Management AS now owns 88,349 shares of the company’s stock worth $6,689,000 after buying an additional 12,247 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.